Lifting the lid on unborn lethal Mendelian phenotypes through exome sequencing
Hanan E Shamseldin1, Abdulrahman Swaid, Fowzan S Alkuraya
1Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Summary
Next-generation sequencing identified a novel CHRNA1 gene mutation causing recurrent fetal loss, revealing a lethal human phenotype. This breakthrough advances understanding of genetic disorders and embryonic development.
Area of Science:
- Genetics
- Human Embryology
- Genomic Medicine
Background:
- Mendelian phenotypes range from benign to lethal, with embryonic lethal forms often undiagnosed due to diagnostic challenges.
- Recurrent fetal loss represents a significant reproductive health issue with frequently unknown genetic causes.
Observation:
- A family experiencing recurrent fetal loss, suspected to have an autosomal recessive inheritance pattern, was investigated.
- The study utilized exome sequencing coupled with autozygome analysis to identify the genetic basis of the condition.
Findings:
- A novel mutation in the CHRNA1 gene was identified as the cause of the recurrent fetal loss.
- The identified CHRNA1 mutation is associated with multiple pterygium and fetal akinesia syndrome, a known lethal phenotype.
Implications:
- This study is the first to demonstrate exome sequencing's efficacy in diagnosing recurrent fetal loss and identifying lethal human phenotypes.
- The findings advocate for systematic application of next-generation sequencing to uncover the spectrum of "unborn" Mendelian disorders in humans.
Related Concept Videos
Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Genomic Imprinting and Inheritance
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.


